Top Institutions in Cardio-Oncology and Heart Failure Management
Institutions were ranked based on their known leadership in cardio-oncology research, heart failure clinical trials, advanced cardiac imaging, and systems-based approaches to cardiogenic shock, reflecting multidisciplinary expertise and contributions to guideline-directed therapies.
-
#1
MD Anderson Cancer Center
Houston, TX
MD Anderson is a global leader in cardio-oncology, with extensive research programs focused on preventing and managing cardiac complications of cancer therapies, including large clinical trials and advanced imaging studies.
Key Differentiators
- Cardio-Oncology
- Heart Failure
- Cancer Therapy-Related Cardiac Dysfunction
-
#2
Mayo Clinic
Rochester, MN
Mayo Clinic is renowned for its multidisciplinary heart failure and cardio-oncology programs, combining clinical care with research in echocardiographic phenotyping and novel therapies for cardiac dysfunction in cancer patients.
Key Differentiators
- Heart Failure
- Cardio-Oncology
- Advanced Cardiac Imaging
-
#3
Brigham and Women's Hospital
Boston, MA
Brigham and Women's has a strong cardio-oncology program and is a leader in heart failure clinical trials and systems-based approaches to managing cardiogenic shock, including regionalized care models.
Key Differentiators
- Cardio-Oncology
- Heart Failure
- Systems-Based Cardiogenic Shock Management
-
#4
Saarland University Hospital
Homburg, Saarland, Germany
Saarland University Hospital, led by Dr. Mert Tokcan, is recognized for its recent contributions to understanding heart failure in patients with prior malignancy and echocardiographic phenotyping of cardiac wasting in cancer.
Key Differentiators
- Cardio-Oncology
- Heart Failure
- Clinical Research
-
#5
University of Texas Southwestern Medical Center
Dallas, TX
UT Southwestern is known for its research in heart failure therapies, cardio-oncology, and outcomes research in cardiogenic shock including mechanical circulatory support, contributing to evidence supporting high-volume center care models.
Key Differentiators
- Heart Failure
- Cardio-Oncology
- Mechanical Circulatory Support
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
